Compare AVO & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | CDNA |
|---|---|---|
| Founded | 1983 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2020 | 2007 |
| Metric | AVO | CDNA |
|---|---|---|
| Price | $12.38 | $21.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $17.00 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 930.8K | 604.0K |
| Earning Date | 06-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.92 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $1,391,200,000.00 | $48,324,000.00 |
| Revenue This Year | N/A | $16.01 |
| Revenue Next Year | $3.06 | $11.31 |
| P/E Ratio | ★ N/A | $408.80 |
| Revenue Growth | 12.68 | ★ 18.93 |
| 52 Week Low | $10.00 | $10.96 |
| 52 Week High | $15.53 | $23.24 |
| Indicator | AVO | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 55.26 |
| Support Level | $11.55 | $15.80 |
| Resistance Level | $13.01 | $21.20 |
| Average True Range (ATR) | 0.45 | 0.99 |
| MACD | -0.10 | -0.17 |
| Stochastic Oscillator | 22.12 | 54.93 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.